Inorganic iron effects on in vitro hypoxic proximal renal tubular cell injury
- PMID: 8432870
- PMCID: PMC288012
- DOI: 10.1172/JCI116251
Inorganic iron effects on in vitro hypoxic proximal renal tubular cell injury
Abstract
Iron-dependent free radical reactions and renal ischemia are believed to be critical mediators of myohemoglobinuric acute renal failure. Thus, this study assessed whether catalytic iron exacerbates O2 deprivation-induced proximal tubular injury, thereby providing an insight into this form of renal failure. Isolated rat proximal tubular segments (PTS) were subjected to either hypoxia/reoxygenation (H/R: 27:15 min), "chemical anoxia" (antimycin A; 7.5 microM x 45 min), or continuous oxygenated incubation +/- ferrous (Fe2+) or ferric (Fe3+) iron addition. Cell injury (% lactic dehydrogenase [LDH] release), lipid peroxidation (malondialdehyde, [MDA]), and ATP depletion were assessed. Under oxygenated conditions, Fe2+ and Fe3+ each raised MDA (approximately 7-10x) and decreased ATP (approximately 25%). Fe2+, but not Fe3+, caused LDH release (31 +/- 2%). During hypoxia, Fe2+ and Fe3+ worsened ATP depletion; however, each decreased LDH release (approximately 31 to approximately 22%; P < 0.01). Fe(2+)-mediated protection was negated during reoxygenation because Fe2+ exerted its intrinsic cytotoxic effect (LDH release: Fe2+ alone, 31 +/- 2%; H/R 36 +/- 2%; H/R + Fe2+, 41 +/- 2%). However, Fe(3+)-mediated protection persisted throughout reoxygenation because it induced no direct cytotoxicity (H/R, 39 +/- 2%; H/R + Fe3+, 25 +/- 2%; P < 0.002). Fe3+ also decreased antimycin toxicity (41 +/- 4 vs. 25 +/- 3%; P < 0.001) despite inducing marked lipid peroxidation and without affecting ATP. These results indicate that catalytic iron can mitigate, rather than exacerbate, O2 deprivation/reoxygenation PTS injury.
Similar articles
-
Effects of inorganic iron and myoglobin on in vitro proximal tubular lipid peroxidation and cytotoxicity.J Clin Invest. 1992 Mar;89(3):989-95. doi: 10.1172/JCI115682. J Clin Invest. 1992. PMID: 1311724 Free PMC article.
-
Differential effects of glutathione and cysteine on Fe2+, Fe3+, H2O2 and myoglobin-induced proximal tubular cell attack.Kidney Int. 1998 Jun;53(6):1661-72. doi: 10.1046/j.1523-1755.1998.00919.x. Kidney Int. 1998. PMID: 9607198
-
Intracellular myoglobin loading worsens H2O2-induced, but not hypoxia/reoxygenation-induced, in vitro proximal tubular injury.Circ Res. 1993 Nov;73(5):926-34. doi: 10.1161/01.res.73.5.926. Circ Res. 1993. PMID: 8403262
-
Evidence against increased hydroxyl radical production during oxygen deprivation-reoxygenation proximal tubular injury.J Am Soc Nephrol. 1992 May;2(11):1627-33. doi: 10.1681/ASN.V2111627. J Am Soc Nephrol. 1992. PMID: 1319220
-
Iron, heme oxygenase, and glutathione: effects on myohemoglobinuric proximal tubular injury.Kidney Int. 1995 Nov;48(5):1624-34. doi: 10.1038/ki.1995.457. Kidney Int. 1995. PMID: 8544424
Cited by
-
Phospholipase A2 activity can protect renal tubules from oxygen deprivation injury.Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8297-301. doi: 10.1073/pnas.90.17.8297. Proc Natl Acad Sci U S A. 1993. PMID: 8367497 Free PMC article.
-
Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA1, and HMG CoA reductase expression.Am J Pathol. 2003 Jan;162(1):283-91. doi: 10.1016/S0002-9440(10)63819-9. Am J Pathol. 2003. PMID: 12507911 Free PMC article.
-
Urine catalytic iron and neutrophil gelatinase-associated lipocalin as companion early markers of acute kidney injury after cardiac surgery: a prospective pilot study.Cardiorenal Med. 2013 Apr;3(1):7-16. doi: 10.1159/000346815. Epub 2013 Feb 6. Cardiorenal Med. 2013. PMID: 23946721 Free PMC article.
-
Renal hypoxia-HIF-PHD-EPO signaling in transition metal nephrotoxicity: friend or foe?Arch Toxicol. 2022 Jun;96(6):1573-1607. doi: 10.1007/s00204-022-03285-3. Epub 2022 Apr 21. Arch Toxicol. 2022. PMID: 35445830 Free PMC article. Review.
-
Urinary exosomes reveal protein signatures in hypertensive patients with albuminuria.Oncotarget. 2017 Jul 4;8(27):44217-44231. doi: 10.18632/oncotarget.17787. Oncotarget. 2017. PMID: 28562335 Free PMC article.